Duquesne University provost, epidemiologist discusses COVID-19 pandemic
Dr. David Dausey has been the Provost at Duquesne University for four years, but a deeper look at his resume shows decades of work to stop the spread of infectious diseases in 20 countries.
After graduate work at Yale and Harvard to study infectious disease, Dr. David Dausey worked at the RAND Corporation preparing governments for a pandemic just like coronavirus.
He said he's not surprised it happened.
"Will this happen again, I think yes. Will it happen sooner than another 100 years? I believe yes, because of globalization of trade and travel and so many factors," Dausey said. "What we can do in advance is to be more prepared."
The world's biggest failure, he says, was communicating a singular message about how to prevent the spread. Dausey also says vaccination progress should have gone even faster than it did.
"We should not have had kids go to school without access to a vaccine. Could we have done something to expedite that so those kids could have been vaccinated this summer in advance of that school year? I believe yes, but that didn't happen," Dausey said.
Dausey believes in more vaccine mandates for COVID-19, just like we have them for other super contagious diseases.
"Measles alone could be shutting down businesses and doing things like COVID-19 is. That's why we made the mandates for measles. We need a similar mandate for COVID-19," Dausey said.
Dausey says we have the power to end the virus quickly.
"If we had 90% vaccine in the population, you would see the disease halted in its tracks, and this is what we want," he said.
As Provost, he says he's proud of how Duquesne University students have accepted the challenge of wearing masks — and that case counts on campus were low last school year.
"How we fare this fall with a disease that is more contagious with a largely vaccinated population is an open question," Dausey said. "The thing that gives me comfort is we know that if you are vaccinated, you are very unlikely to get the severe disease or have a severe complication."
As for vaccination approval for children younger than age 12, Dausey expects that to happen sometime this fall.